| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Feb―19 |
Vaccine-elicited immune pressure and SARS-CoV-2 mutational dynamics in breakthrough infections |
Sarwareddy Kartik Kumar, Srinivas Sathrasala, Jandhyala Sai Krishna, Patnam Sreekanth, Anula Divyash Singh, M.S. Ratnamani, Iravathy Goud Kalal, Karthik Bharadwaj Tallapaka, Gajjela Praveen Kumar, Manda Venkata Sasidhar, Swarna Deepak Kurrayagayala |
| 2 |
[GO] |
2023―Nov―27 |
Codon usage patterns of the eleven SARS-CoV-2 variants with reference to the Wuhan sequence |
Md Samim Hassan, Syed Sahajada Mahafujul Alam, Arijit Samanta, Mehboob Hoque, Safdar Ali |
| 3 |
[GO] |
2023―Oct―07 |
Unveiling sex-based impact of TYK2 rs2304256 polymorphism on interferon beta-1alpha responsiveness in COVID-19 patients |
Zeynab Cheraghi, Seyed Ali Ziai, Zahra Fazeli, Abbas Gheisoori |
| 4 |
[GO] |
2023―Aug―20 |
Gene expression changes in COVID-19 patients impact pathways related to circadian rhythm, phosphatidylinositol signaling, cytokine storm, and platelet aggregation |
Shail Modi, Nandini Gandhi, Hoeyoon Yoon, Jeihun Kuack, Hyejoo Jee, Chidinma Enwere, Onel Iskarous, Walaa Farag, George Acquaah-Mensah |
| 5 |
[GO] |
2023―Jul―23 |
The genotype A/A and C/C of rs17878703 and rs3175105, respectively in HLA-DRB1 confers risk of COVID-19 severity in Bangladeshi population |
Abdullah Al Saba, Sajib Chakraborty, Jasmin Nur, Md Sohrab Alam, Zakir Hossain Howlader, A.H.M. Nurun Nabi, Laila Noor Islam |
| 6 |
[GO] |
2023―Jul―01 |
The association of PON1 and NOS3 genetic variants with the severity of COVID-19 |
Moez A. Eid, Anzhela A. Aleksandrova, Mikhail A. Shkurat, Tatiana P. Shkurat |
| 7 |
[GO] |
2023―Feb―02 |
Evaluation of Tcell exhaustion based on the expression of EOMES, Tbet and co-inhibitory receptors in severe and non-severe covid-19 patients |
Amir Mohammad Saeedifar, Khodayar Ghorban, Ali Ganji, Ghasem Mosayebi, Mohammad Gholami, Maryam Dadmanesh, Negin Hosseini Rouzbahani |
| 8 |
[GO] |
2022―Nov―04 |
Whole exome sequencing identifies a rare variant in MAS1 gene in a subject with lethal COVID-19 |
Alessia Azzarà, Ilaria Cassano, Maria Cristina Tirindelli, Carolina Nobile, Valentina Schittone, Elisa Paccagnella, Carla Lintas, Fiorella Gurrieri |
| 9 |
[GO] |
2022―Oct―30 |
Emergence and spreading of the largest SARS-CoV-2 deletion in the Delta AY.20 lineage from Uruguay |
Yanina Panzera, Maria Noel Cortinas, Ana Marandino, Lucía Calleros, Victoria Bormida, Natalia Goñi, Claudia Techera, Sofía Grecco, Joaquín Williman, Viviana Ramas, Leticia Coppola, Cristina Mogdasy, Héctor Chiparelli, Ruben Pérez |
| 10 |
[GO] |
2022―Jul―16 |
miRNA expression in COVID-19 |
Kiarash Roustai Geraylow, Romina Hemmati, Sepideh Kadkhoda, Soudeh Ghafouri-Fard |
| 11 |
[GO] |
2022―Jun―14 |
Characterization of mutations modulating enhanced transmissibility of SARS-CoV-2 B.1.617+ (Delta) variant using In Silico tools |
Nariman Shahhosseini |
| 12 |
[GO] |
2022―May―19 |
SARS-CoV-2 and HIV co-infection; clinical features, diagnosis, and treatment strategies: A systematic review and meta-analysis |
Masoud Dadashi, Ali Dadashi, Fatemeh Sameni, Shahram Sayadi, Mehdi Goudarzi, Mohammad Javad Nasiri, Somayeh Yaslianifard, Mona Ghazi, Reza Arjmand, Bahareh Hajikhani |
| 13 |
[GO] |
2022―May―04 |
Therapeutic approaches and vaccination in fighting COVID-19 infections: A review |
Setare Adibzadeh, Shahin Amiri, Giti Esmail Nia, Maryam Rezakhani Taleghani, Zahra Kohanrooz Bijarpas, Neda Maserat, Amirhosein Maali, Mehdi Azad, Abbas Behzad-Behbahani |
| 14 |
[GO] |
2022―Apr―18 |
COVID-19 susceptibility, severity, clinical outcome and Toll-like receptor (7) mRNA expression driven by TLR7 gene polymorphism (rs3853839) in middle-aged individuals without previous comorbidities |
Sally M. El-Hefnawy, Hanaa A. Eid, Rasha G. Mostafa, Shaimaa S. Soliman, Thoria A. Omar, Rania M. Azmy |
| 15 |
[GO] |
2022―Apr―04 |
The status and analysis of common mutations found in the SARS-CoV-2 whole genome sequences from Bangladesh |
Sadniman Rahman, Md. Asaduzzaman Shishir, Md Ismail Hosen, Miftahul Jannat Khan, Ashiqul Arefin, Ashfaqul Muid Khandaker |
| 16 |
[GO] |
2022―Mar―18 |
Using bioinformatics and systems biology to discover common pathogenetic processes between sarcoidosis and COVID-19 |
Lanyi Fu, Maolin Yao, Xuedong Liu, Dong Zheng |
| 17 |
[GO] |
2022―Mar―08 |
Fungal and bacterial co-infections of the respiratory tract among patients with COVID-19 hospitalized in intensive care units |
Zahra Rafat, Alireza Ramandi, Pegah Afarinesh Khaki, Saham Ansari, Sara Ghaderkhani, Hassan Haidar, Faezeh Tajari, Davoud Roostaei, Roshanak Daei Ghazvini, Seyed Jamal Hashemi, Alireza Abdollahi, Hasti Kamali Sarvestani |
| 18 |
[GO] |
2022―Feb―22 |
WITHDRAWN: Genetic diversity of Mycobacterium tuberculosis isolates from northwest of Iran during Covid-19 era |
Peyvand Kashi, Farzaneh Pakdel, Mohammad Hossein Soroush Barhaghi, Mohammad Ahangarzadeh Rezaee, Sepehr Taghizadeh, Javid Sadeghi, Mehdi Yousefi, Reza Ghotaslou, Mohammad Asgharzadeh, Pourya Gholizadeh, Hossein Samadi Kafil |
| 19 |
[GO] |
2022―Feb―10 |
Omicron: A highly transmissible SARS-CoV-2 variant |
Farid Rahimi, Amin Talebi Bezmin Abadi |
| 20 |
[GO] |
2022―Feb―08 |
Insights into the mutation T1117I in the spike and the lineage B.1.1.389 of SARS-CoV-2 circulating in Costa Rica |
Jose Arturo Molina-Mora |
| 21 |
[GO] |
2022―Feb―02 |
Highlight of potential impact of new viral genotypes of SARS-CoV-2 on vaccines and anti-viral therapeutics |
Abozar Ghorbani, Samira Samarfard, Maziar Jajarmi, Mahboube Bagheri, Thomas P. Karbanowicz, Alireza Afsharifar, Mohammad Hadi Eskandari, Ali Niazi, Keramatollah Izadpanah |
| 22 |
[GO] |
2022―Jan―15 |
Global data analysis and risk factors associated with morbidity and mortality of COVID-19 |
Sina Salajegheh Tazerji, Fatemeh Shahabinejad, Mahya Tokasi, Mohammad Ali Rad, Muhammad Sajjad Khan, Muhammad Safdar, Krzysztof J. Filipiak, Lukasz Szarpak, Tomasz Dzieciatkowski, Jan Jurgiel, Phelipe Magalhãses Duarte, Md. Tanvir Rahman, Md. Abdus Sobur, Md. Saiful Islam, Adnan Ahmed, Mohamed N.F. Shahen, Awad A. Shehata, Rasha Gharieb, Mohamed Fawzy, Yashpal Singh Malik, Nagaraj Jaganathasamy, Vinodhkumar Obli Rajendran, Kannan Subbaram, Shaik Syed Ali Pakeer, Sheeza Ali, Saif Ur Rehman, Mehmet Ozaslan, Gulfaraz Khan, Muhammad Saeed, Umair Younas, Safdar Imran, Yasmeen Junejo, Parmida Arabkarami, Unarose Hogan, Alfonso J. Rodriguez-Morales |
| 23 |
[GO] |
2022―Jan―15 |
RNAi-mediated siRNA sequences to combat the COVID-19 pandemic with the inhibition of SARS-CoV2 |
Khandakar A.S.M. Saadat |
| 24 |
[GO] |
2022―Jan―15 |
Serum levels of vitamin D and immune system function in patients with COVID-19 admitted to intensive care unit |
Mohammad Sadegh Soltani-Zangbar, Ata Mahmoodpoor, Sanam Dolati, Ali Shamekh, Sepehr Valizadeh, Mehdi Yousefi, Sarvin Sanaie |
| 25 |
[GO] |
2022―Jan―15 |
The impact of lymphoid memory cells in different ages of COVID-19 patients |
Mozhdeh Jafari, Hanieh Kolahdooz, Mahmoud Mahmoudi, Afsaneh Foolady Azarnaminy, Leila Mobasheri, Seyed-Alireza Esmaeili |
| 26 |
[GO] |
2022―Jan―15 |
Investigation of CYP2E1 and Caspase-3 Gene Expressions in COVID-19 patients |
S. Karabulut Uzuncakmak, E. Dirican, M.E. Naldan, F. Kesmez Can, Z. Halıcı |
| 27 |
[GO] |
2022―Jan―14 |
Enhanced endocytosis elevated virulence and severity of SARS-CoV-2 due to hyperglycemia in type 2 diabetic patients |
Kannan Subbaram, P. Shaik Syed Ali, Sheeza Ali |
| 28 |
[GO] |
2021―Nov―27 |
Evaluation of biochemical characteristics of 183 COVID-19 patients: A retrospective study |
Seyed Mostafa Mir, Alireza Tahamtan, Hadi Razavi Nikoo, Mehdi Sheikh Arabi, Abdul Wahab Moradi, Saeed Ardakanian, Alijan Tabarraei |
| 29 |
[GO] |
2021―Nov―26 |
Binder design for targeting SARS-CoV-2 spike protein: An in silico perspective |
Ali Etemadi, Hamid Reza Moradi, Farideh Mohammadian, Mohammad Hossein Karimi-Jafari, Babak Negahdari, Yazdan Asgari, Mohammadali Mazloomi |
| 30 |
[GO] |
2021―Nov―20 |
Effect of temperature and humidity on coronavirus infection in Pakistan |
Fazal Akbar, Muhammad Suleman, Muhammad Israr, Syed Shujait Ali, Nasib Zaman, Owais Khan, Jawad Ali, Waqar Ahmad, Murad Ali Rahat, Akhtar Rasool, Muzafar Shah, Zahid Hussain, Mohammad Ali |
| 31 |
[GO] |
2021―Nov―05 |
Immunopathology and Immunopathogenesis of COVID-19, what we know and what we should learn |
Mehdi Shahgolzari, Afagh Yavari, Yaser Arjeini, Seyed Mohammad Miri, Amirhossein Darabi, Amir Sasan Mozaffari Nejad, Mohsen Keshavarz |
| 32 |
[GO] |
2021―Nov―04 |
Analysis of SARS-COV2 spike protein variants among Iraqi isolates |
Dana Khdr Sabir |
| 33 |
[GO] |
2021―Oct―25 |
Comparative study of SARS-CoV-2 antibody titers between male and female COVID-19 patients living in Kurdistan region of Iraq |
Sonia Elia Ishaq, Shang Ziyad Abdulqadir, Zhikal Omar Khudhur, Shwan Ali Omar, Mahdi Khaled Qadir, Harem Khdir Awla, Mohammed Fatih Rasul, Ahmed Abdulrazzaq Bapir, Anna Zanichelli, Muhammad Khalid Mansoor, Muhammad Kaleem, Muhammad Arif Rizwan, Shukur Wasman Smail, Esmaeil Babaei |
| 34 |
[GO] |
2021―Oct―04 |
SARS-CoV-2 Lambda (C.37): An emerging variant of concern? |
Mohammad Darvishi, Farid Rahimi, Amin Talebi Bezmin Abadi |
| 35 |
[GO] |
2021―Sep―03 |
Emergence of the Delta Plus variant of SARS-CoV-2 in Iran |
Farid Rahimi, Amin Talebi Bezmin Abadi |
| 36 |
[GO] |
2021―Sep―03 |
Impact of new UK (B.1.1.7) SARS-Cov-2 variant on interacting with ACE2 and host immune response |
Alireza Paniri, Mohammad Mahdi Hosseini, Haleh Akhavan-Niaki |
| 37 |
[GO] |
2021―Aug―12 |
Systems level insights into the impact of airborne exposure on SARS-CoV-2 pathogenesis and COVID-19 outcome - A multi-omics big data study |
Jeganathan Manivannan, Lakshmikirupa Sundaresan |
| 38 |
[GO] |
2021―Jul―07 |
Relevance of vitamin D3 in COVID-19 infection |
Falaque Ul Afshan, Bushra Nissar, Nisar Ahmad Chowdri, Bashir Ahmad Ganai |
| 39 |
[GO] |
2021―Jun―11 |
A bioinformatics approach for identifying potential molecular mechanisms and key genes involved in COVID-19 associated cardiac remodeling |
Hamid Ceylan |
| 40 |
[GO] |
2021―Jun―11 |
SARS-CoV-2 mutations altering regulatory properties: deciphering host's and virus's perspectives |
Abul Bashar Mir Md. Khademul Islam, Md. Abdullah-Al-Kamran Khan |
| 41 |
[GO] |
2021―May―19 |
Approximative He Hamiltonian in descriptive multidimensional scaling statistics of RNA contained information with application to SARS-CoV-2 Spike mRNA and 7SLRNA, RN7SL2 and RN7SL3 |
Han Geurdes |
| 42 |
[GO] |
2021―May―07 |
Diversity and genomic determinants of the microbiomes associated with COVID-19 and non-COVID respiratory diseases |
M. Nazmul Hoque, M. Shaminur Rahman, Rasel Ahmed, Md. Sabbir Hossain, Md. Shahidul Islam, Tofazzal Islam, M. Anwar Hossain, A.M.A.M. Zonaed Siddiki |
| 43 |
[GO] |
2021―May―05 |
Analysis of single nucleotide polymorphisms between 2019-nCoV genomes and its impact on codon usage |
Suruchi Gupta, Prosenjit Paul, Ravail Singh |
| 44 |
[GO] |
2021―Apr―16 |
Whole genome comparison of Pakistani Corona virus with Chinese and US strains along with its predictive severity of COVID-19 |
Rashid Saif, Tania Mahmood, Aniqa Ejaz, Saeeda Zia, Abdul Rasheed Qureshi |
| 45 |
[GO] |
2021―Apr―14 |
Application of newly developed SARS-CoV2 serology test along with real-time PCR for early detection in health care workers and on-time plasma donation |
Mohammad Sadegh Soltani-Zangbar, Leili Aghebati-Maleki, Mahsa Hajivalili, Mostafa Haji-Fatahaliha, Roza Motavalli, Ata Mahmoodpoor, Hossein Samadi Kafil, Sara Farhang, Ramin Pourakbari, Farhad Jadidi-Niaragh, Leila Roshangar, Javad Ahmadian Heris, Amin Kamrani, Homayoon Siahmansouri, Maryam Hosseini, Abolfazl Miahipour, Oldouz Shareghi-Oskoue, Forough Parhizkar, Mehdi Yousefi |
| 46 |
[GO] |
2021―Apr―01 |
An overview of basic molecular biology of SARS-CoV-2 and current COVID-19 prevention strategies |
Ankur Das, Raja Ahmed, Suraiya Akhtar, Khaleda Begum, Sofia Banu |
| 47 |
[GO] |
2021―Mar―23 |
Comparative analysis of mutational hotspots in the spike protein of SARS-CoV-2 isolates from different geographic origins |
Sanghoo Lee, Mi-Kyeong Lee, Hyeongkyun Na, Jinwoo Ahn, Gayeon Hong, Youngkee Lee, Jimyeong Park, Yejin Kim, Yun-Tae Kim, Chang-Ki Kim, Hwan-Sub Lim, Kyoung-Ryul Lee |
| 48 |
[GO] |
2021―Mar―20 |
Exploring unprecedented problems of academicians during the COVID 19 pandemic and their relationships with fatigue and mental health |
Fakhradin Ghasemi, Maryam Zarei, Rashid Heidarimoghadam, Seyed Mostafa Hosseini |
| 49 |
[GO] |
2021―Mar―12 |
ACE2: At the crossroad of COVID-19 and lung cancer |
Gunnar Gottschalk, Konstance Knox, Avik Roy |
| 50 |
[GO] |
2021―Mar―01 |
Analysis and comparison of genetic variants and mutations of the novel coronavirus SARS-CoV-2 |
Zaid Almubaid, Hisham Al-Mubaid |
| 51 |
[GO] |
2021―Feb―21 |
Characterizing genomic variants and mutations in SARS-CoV-2 proteins from Indian isolates |
Jayanta Kumar Das, Antara Sengupta, Pabitra Pal Choudhury, Swarup Roy |
| 52 |
[GO] |
2021―Feb―18 |
A comparative genomics-based study of positive strand RNA viruses emphasizing on SARS-CoV-2 utilizing dinucleotide signature, codon usage and codon context analyses |
Jayanti Saha, Sukanya Bhattacharjee, Monalisha Pal Sarkar, Barnan Kumar Saha, Hriday Kumar Basak, Samarpita Adhikary, Vivek Roy, Parimal Mandal, Abhik Chatterjee, Ayon Pal |
| 53 |
[GO] |
2021―Feb―17 |
SARS-CoV-2 spillover transmission due to recombination event |
Nariman Shahhosseini, Gary Wong, Gary P. Kobinger, Sadegh Chinikar |
| 54 |
[GO] |
2021―Feb―16 |
Corrigendum to “mTOR inhibition and p53 activation, microRNAs: The possible therapy against pandemic COVID-19” [Gene Rep. 20 (2020) 100765] |
Mekala Janaki Ramaiah |
| 55 |
[GO] |
2021―Jan―26 |
Genome-wide in silico identification and characterization of Simple Sequence Repeats in diverse completed SARS-CoV-2 genomes |
Rasel Siddiqe, Ajit Ghosh |
| 56 |
[GO] |
2021―Jan―18 |
Mutational analysis of SARS-CoV-2 ORF8 during six months of COVID-19 Pandemic |
Ahmad ALKHANSA, Ghayas LAKKIS, Loubna E.L. ZEIN |
| 57 |
[GO] |
2020―Dec―31 |
Computationally predicted SARS-COV-2 encoded microRNAs target NFKB, JAK/STAT and TGFB signaling pathways |
Merve Nur Aydemir, Habes Bilal Aydemir, Ertan Mahir Korkmaz, Mahir Budak, Nilgun Cekin, Ergun Pinarbasi |
| 58 |
[GO] |
2020―Dec―08 |
Mutational insights into the envelope protein of SARS-CoV-2 |
M. Shaminur Rahman, M. Nazmul Hoque, M. Rafiul Islam, Israt Islam, Israt Dilruba Mishu, Md. Mizanur Rahaman, Munawar Sultana, M. Anwar Hossain |
| 59 |
[GO] |
2020―Dec―04 |
Comprehensive in silico identification of impacts of ACE2 SNPs on COVID-19 susceptibility in different populations |
Alireza Paniri, Mohammad Mahdi Hosseini, Mojtaba Moballegh Eslam, Haleh Akhavan-Niaki |
| 60 |
[GO] |
2020―Nov―27 |
Gene expression profiling of corona virus microarray datasets to identify crucial targets in COVID-19 patients |
Priyanka Ramesh, Shanthi Veerappapillai, Ramanathan Karuppasamy |
| 61 |
[GO] |
2020―Nov―05 |
Bioinformatics analyses of significant genes, related pathways, and candidate diagnostic biomarkers and molecular targets in SARS-CoV-2/COVID-19 |
Basavaraj Vastrad, Chanabasayya Vastrad, Anandkumar Tengli |
| 62 |
[GO] |
2020―Nov―01 |
Genomic exploration light on multiple origin with potential parsimony-informative sites of the severe acute respiratory syndrome coronavirus 2 in Bangladesh |
Otun Saha, Md. Shahadat Hossain, Md. Mizanur Rahaman |
| 63 |
[GO] |
2020―Oct―17 |
Genetic variations among SARS-CoV-2 strains isolated in China |
Eltayib H. Ahmed-Abakur, Tarig M.S. Alnour |
| 64 |
[GO] |
2020―Oct―07 |
Determination of COVID-19 prevalence with regards to age range of patients referring to the hospitals located in western Tehran, Iran |
Hamidreza Kalantari, Aida Haji Hossein Tabrizi, Fatemeh Foroohi |
| 65 |
[GO] |
2020―Sep―28 |
Identification of twenty-five mutations in surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics |
Gyanendra Bahadur Chand, Atanu Banerjee, Gajendra Kumar Azad |
| 66 |
[GO] |
2020―Sep―14 |
Genetic characterization of structural and open reading Fram-8 proteins of SARS-CoV-2 isolates from different countries |
Abdullah Shah, Farooq Rashid, Abdul Aziz, Amin Ullah Jan, Muhammad Suleman |
| 67 |
[GO] |
2020―Aug―28 |
In silico structure modelling of SARS-CoV-2 Nsp13 helicase and Nsp14 and repurposing of FDA approved antiviral drugs as dual inhibitors |
Arun Bahadur Gurung |
| 68 |
[GO] |
2020―Jul―08 |
Phylogenomic proximity and comparative proteomic analysis of SARS-CoV-2 |
R. Prathiviraj, George Seghal Kiran, Joseph Selvin |
| 69 |
[GO] |
2020―Jun―30 |
mTOR inhibition and p53 activation, microRNAs: The possible therapy against pandemic COVID-19 |
M. Janaki Ramaiah |
| 70 |
[GO] |
2020―Jun―16 |
COVID-19: What you need to know |
Hossam HILAL EL IDRISSI |
| 71 |
[GO] |
2020―Jun―15 |
Novel SARS-CoV-2/COVID-19: Origin, pathogenesis, genes and genetic variations, immune responses and phylogenetic analysis |
Yasmeen Junejo, Mehmet Ozaslan, Muhamad Safdar, Rozhgar A. Khailany, SaifUr Rehman, Wasim Yousaf, Musarrat Abbas Khan |
| 72 |
[GO] |
2020―May―30 |
COVID-19 target: A specific target for novel coronavirus detection |
Reza Kamali Kakhki, Mohammad Kamali Kakhki, Alireza Neshani |
| 73 |
[GO] |
2020―Apr―16 |
Genomic characterization of a novel SARS-CoV-2 |
Rozhgar A. Khailany, Muhamad Safdar, Mehmet Ozaslan |
